Safety of Lung Cryobiopsy in People With Cancer
NCT04548830 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-05-06
Summary
The purpose of this study is to find out whether a biopsy technique called transbronchial cryobiopsy (TBCB) is a safe alternative to the standard biopsy procedure (transbronchial forceps biopsy; TBFB). The study researchers think that TBCB may provide better biopsy samples to help diagnose lung disease.
Conditions
Interventions
- PROCEDURE
-
Transbronchial cryobiopsy
After enrollment, and pre-treatment procedures are complete, patients will undergo flexible bronchoscopy with a therapeutic bronchoscope under general anesthesia via an advanced airway at Memorial Hospital in an inpatient or outpatient setting.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Or Kalchiem-Dekel, MD · Memorial Sloan Kettering Cancer Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-08
- Primary Completion
- 2027-09-30
- Completion
- 2027-09-30
Countries
- United States
Study Locations
More Related Trials
-
Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva
NCT05122507 ·Status: UNKNOWN
-
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
NCT07327489 ·Status: RECRUITING
-
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
NCT06482073 ·Status: RECRUITING
-
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
NCT00568490 ·Status: RECRUITING
-
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723 ·Status: RECRUITING
-
Rapid Autopsy and Procurement of Cancer Tissue
NCT01851395 ·Status: TERMINATED
-
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
NCT01365949 ·Status: COMPLETED
-
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
NCT02245100 ·Status: COMPLETED
-
Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC
NCT03302325 ·Status: COMPLETED
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
NCT01137643 ·Status: RECRUITING
-
Liquid Biopsy Collection Study
NCT06068348 ·Status: ACTIVE_NOT_RECRUITING
-
Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell Carcinoma
NCT04599309 ·Status: ACTIVE_NOT_RECRUITING
-
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma
NCT03896620 ·Status: RECRUITING
-
PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy
NCT00530283 ·Status: COMPLETED
-
Molecular Analysis of Thoracic Malignancies
NCT01385722 ·Status: ENROLLING_BY_INVITATION
-
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
NCT06958107 ·Status: RECRUITING
-
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
NCT00588510 ·Status: COMPLETED
-
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
NCT00898313 ·Status: RECRUITING
-
Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx
NCT00899340 ·Status: COMPLETED
-
Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy
NCT01078350 ·Status: COMPLETED
-
Wet Heparinized Suction for Abdominal Cancer
NCT05041335 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
NCT00610415 ·Status: COMPLETED
-
Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT00001823 ·Status: RECRUITING
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
NCT04490564 ·Status: COMPLETED